Grace Therapeutics
GRCE
14 hedge funds and large institutions have $5.29M invested in Grace Therapeutics in 2014 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 4 increasing their positions, 2 reducing their positions, and 3 closing their positions.
100% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 2
13% less funds holding
Funds holding: 16 → 14 (-2)
21% less capital invested
Capital invested by funds: $6.71M → $5.29M (-$1.41M)
67% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
1832 Asset Management
Toronto,
Ontario, Canada
|
+$166K |
| 2 |
VKH
Virtu KCG Holdings
New York
|
+$44.7K |
| 3 |
Bank of Montreal
Toronto,
Ontario, Canada
|
+$31K |
| 4 |
PA
Perceptive Advisors
New York
|
+$7.05K |
| 5 |
U
UBS
Zurich,
Switzerland
|
+$4.7K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jane Street
New York
|
-$30K |
| 2 |
IIM
Intact Investment Management
Montreal,
Quebec, Canada
|
-$26.8K |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$20K |
| 4 |
Citigroup
New York
|
-$7.52K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
PA
1
Perceptive Advisors
New York
| $1.98M | +$7.05K | +15 | +0.3% |
|
2
Fiera Capital (Canada)
Montreal,
Quebec, Canada
| $1.25M | – | – | – |
|
|
IIM
3
Intact Investment Management
Montreal,
Quebec, Canada
| $1.09M | -$26.8K | -57 | -2% |
|
|
4
Bank of Montreal
Toronto,
Ontario, Canada
| $763K | +$31K | +66 | +3% |
|
|
5
1832 Asset Management
Toronto,
Ontario, Canada
| $122K | +$166K | +353 | New |
|
|
VKH
6
Virtu KCG Holdings
New York
| $54K | +$44.7K | +95 | +164% |
|
|
U
7
UBS
Zurich,
Switzerland
| $15K | +$4.7K | +10 | +32% |
|
8
Geode Capital Management
Boston,
Massachusetts
| $13K | – | – | – |
|
|
LTFS
9
Ladenburg Thalmann Financial Services
Miami,
Florida
| $3K | – | – | – |
|
|
CP
10
Corbenic Partners
Bethlehem,
Pennsylvania
| $1K | – | – | – |
|
|
EWM
11
Edge Wealth Management
New York
| $1K | – | – | – |
|
12
Royal Bank of Canada
Toronto,
Ontario, Canada
| $1K | – | – | – |
|
|
13
Jane Street
New York
| – | -$30K | -62 | Closed |
|
|
14
Citadel Advisors
Miami,
Florida
| – | -$20K | -40 | Closed |
|
|
15
Citigroup
New York
| – | -$7.52K | -16 | -94% |
|
GRCE Hedge Fund Activity: Q3 2014 in Review
14 of the 3,448 institutional investors tracked by Wall St. Rank reported a position in Grace Therapeutics (GRCE) for Q3 2014, worth a combined $5.29M — down 21% from $6.71M a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of GRCE and 1 opened new positions — a net loss of 2 holders — while 2 trimmed existing stakes and 4 added.
The largest buyer was 1832 Asset Management, opening a new position worth an estimated $166K. The largest seller was Jane Street, exiting entirely with an estimated $30K sold.
- 14 institutional investors held Grace Therapeutics (GRCE) as of Q3 2014, down from 16 in Q2 2014.
- Funds reported $5.29M of Grace Therapeutics stock for Q3 2014, down 21% quarter-over-quarter.
- 1 fund opened new Grace Therapeutics positions in Q3 2014 and 3 closed out, a net change of -2 holders.
- The largest Grace Therapeutics buyer in Q3 2014 was 1832 Asset Management, an estimated $166K added.
- The largest Grace Therapeutics seller in Q3 2014 was Jane Street, an estimated $30K sold.
Based on aggregated 13F filings for Q3 2014.